Varian recently acquired Evinance Innovation, Inc., a Montreal-based company focused on developing clinical decision support (CDS) software. The Evinance Decision Support™ solution, which is being incorporated into Varian’s 360 Oncology™ care management platform, integrates clinical workflow, decision support, and adherence tracking in oncology based on leading cancer care guidelines such as those from the National Comprehensive Cancer Network® (NCCN®).
Through this integration, clinicians will have a platform for visualizing a patient's journey while applying the leading evidence-based guidelines so that doctors and patients can make informed treatment decisions together.
"With healthcare reimbursement models moving to value-based patient care, it is critical for clinicians to be equipped with the tools that make it easier for them to provide evidence-based and coordinated care consistently across clinical settings," said Kolleen Kennedy, president of Varian's Oncology Systems business. "With this acquisition and integration of the Evinance platform into 360 Oncology, we are moving closer to our goal of delivering a comprehensive cancer care operating system that helps clinicians make more informed decisions at the point of care."
For more information on Evinance and 360 Oncology, visit www.varian.com/evinance.